30284415
2016
The article reviews contemporary data about influences of sex hormons (androgenes, estrogenes) and their nuclear receptors on development of hepatocellular carcinoma. Use of hepatoprotective drugs for treatment of chronic liver diseases and prophylactic of hepatocellular carcinoma should be correlated with potential hormonal effects of the treatment.

